EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cardiotoxicity in platinum-based chemotherapy: Mechanisms, manifestations, and management

Betty Rachma, Merlyna Savitri, Henry Sutanto

Cancer Pathogenesis and Therapy · 2025-03 · 3 (2) · 101-108

DOI: 10.1016/j.cpt.2024.04.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Pathogenesis and Therapy, 2025-03. Verfasst von Betty Rachma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, 60132, Indonesia. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum-based chemotherapy, a cornerstone in the treatment of various malignancies, is often limited by its potential cardiotoxic effects. Understanding these effects is crucial for optimizing patient outcomes and guiding treatment decisions. This review explores the mechanisms, clinical manifestations, detection, management, and future directions in the research of cardiotoxicity associated with platinum-based chemotherapy. The mechanisms discussed here include oxidative stress, reactive oxygen species production, DNA damage, and alterations in signaling pathways. Clinical manifestations range from mild symptoms to severe complications, including Takotsubo cardiomyopathy, as highlighted by recent case studies. The role of diagnostic tools such as echocardiography, cardiac magnetic resonance imaging, and cardiac biomarkers in early detection is emphasized, underscoring the importance of regular cardiac monitoring. Management strategies focus on cardioprotective agents, alternative chemotherapy regimens, and emerging therapeutic approaches, including the potential of nano liposomal and cubosomal formulations. The review also delves into the future of personalized medicine in predicting and managing cardiotoxicity, advocating for ongoing research to mitigate these adverse effects. This comprehensive overview aims to enhance the understanding of cardiotoxicity in platinum-based chemotherapy, informing clinical practices and promoting patient-centric care.

Schlagwörter

Stichwörter der Autor:innen

CancerCardiotoxic agentsCardiovascular diseaseChemotherapyOncologyPlatinum

Autor:innen und Institutionen

  • Internal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, 60132, Indonesia.
  • Department of Internal Medicine, Dr. Soetomo General Academic Hospital, Surabaya, 60286, Indonesia.
  • Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, 60132, Indonesia.

Zitieren

APA

Rachma, B., Savitri, M., & Sutanto, H. (2025). Cardiotoxicity in platinum-based chemotherapy: Mechanisms, manifestations, and management. Cancer Pathogenesis and Therapy, 3(2), 101-108. https://doi.org/10.1016/j.cpt.2024.04.004

Vancouver

Rachma B, Savitri M, Sutanto H. Cardiotoxicity in platinum-based chemotherapy: Mechanisms, manifestations, and management. Cancer Pathogenesis and Therapy. 2025;3(2):101-108. doi:10.1016/j.cpt.2024.04.004

BibTeX
@article{Rachma2025,
  author = {Rachma, Betty and Savitri, Merlyna and Sutanto, Henry},
  title = {Cardiotoxicity in platinum-based chemotherapy: Mechanisms, manifestations, and management},
  journal = {Cancer Pathogenesis and Therapy},
  year = {2025},
  volume = {3},
  number = {2},
  pages = {101--108},
  doi = {10.1016/j.cpt.2024.04.004}
}
Kostenlos starten →